Overview

Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Hydroxyethyl starch (HES) is commonly used as plasma expander during surgery but may be nephrotoxic as seen in studies in patients with sepsis. The investigators hypothesized that the possible nephrotoxicity of 6% HES 130/0.4 could be revealed by measurements of urinary and plasma neutrophil gelatinase-associated lipocalin and interleukin-18 (IL-18) in old patients with normal renal function during orthopaedic surgery.
Phase:
N/A
Details
Lead Sponsor:
Yuanyuan Zhang
Collaborators:
Tianjin First Central Hospital
Tianjin Union Medical Center
Treatments:
Hydroxyethyl Starch Derivatives